3eoa: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:3eoa.png|left|200px]] | [[Image:3eoa.png|left|200px]] | ||
{{STRUCTURE_3eoa| PDB=3eoa | SCENE= }} | {{STRUCTURE_3eoa| PDB=3eoa | SCENE= }} | ||
===Crystal structure the Fab fragment of Efalizumab in complex with LFA-1 I domain, Form I=== | ===Crystal structure the Fab fragment of Efalizumab in complex with LFA-1 I domain, Form I=== | ||
{{ABSTRACT_PUBMED_19258452}} | {{ABSTRACT_PUBMED_19258452}} | ||
==About this Structure== | ==About this Structure== | ||
[[3eoa]] is a 6 chain structure of [[Monoclonal Antibody]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3EOA OCA]. | |||
==See Also== | |||
*[[Monoclonal Antibody|Monoclonal Antibody]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:019258452</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Ding, J.]] | [[Category: Ding, J.]] | ||
[[Category: Li, S.]] | [[Category: Li, S.]] | ||
[[Category: Antibody]] | [[Category: Antibody]] | ||
[[Category: Cd11a]] | [[Category: Cd11a]] | ||
[[Category: Efalizumab]] | [[Category: Efalizumab]] | ||
Line 35: | Line 24: | ||
[[Category: Glycoprotein]] | [[Category: Glycoprotein]] | ||
[[Category: I domain]] | [[Category: I domain]] | ||
[[Category: Immune system | [[Category: Immune system-cell adhesion complex]] | ||
[[Category: Integrin]] | [[Category: Integrin]] | ||
[[Category: Lfa-1]] | [[Category: Lfa-1]] | ||
[[Category: Magnesium]] | [[Category: Magnesium]] | ||
[[Category: Membrane]] | [[Category: Membrane]] | ||
[[Category: Receptor]] | [[Category: Receptor]] | ||
[[Category: Transmembrane]] | [[Category: Transmembrane]] | ||